Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia
Clinical trial NCT03850730 · UNKNOWN
Trial details
- NCT number
- NCT03850730
- Sponsor
- Cure HHT
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2025-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.